Accueil>>Signaling Pathways>> PROTAC>>Tos-PEG4-t-butyl ester

Tos-PEG4-t-butyl ester

Catalog No.GC38867

Tos-PEG4-t-butyl ester (Tos-PEG4-Boc) est un lieur PROTAC, qui fait référence À la composition du PEG. Le Tos-PEG4-t-butyl ester (Tos-PEG4-Boc) peut être utilisé dans la synthèse d'une série de PROTAC, comme le BI-3663. BI-3663 est un PTK2/FAK PROTAC hautement sélectif, avec des ligands cereblon pour détourner les ligases E3 pour la dégradation de PTK2, et inhibe PTK2 avec une IC50 de 18 nM.

Products are for research use only. Not for human use. We do not sell to patients.

Tos-PEG4-t-butyl ester Chemical Structure

Cas No.: 217817-01-1

Taille Prix Stock Qté
10mg
46,00 $US
En stock
25mg
72,00 $US
En stock
50mg
124,00 $US
En stock
100mg
209,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Tos-PEG4-t-butyl ester (Tos-PEG4-Boc) is a PROTAC linker, which refers to the PEG composition. Tos-PEG4-t-butyl ester (Tos-PEG4-Boc) can be used in the synthesis of a series of PROTACs, such as BI-3663 . BI-3663 is a highly selective PTK2/FAK PROTAC, with cereblon ligands to hijack E3 ligases for PTK2 degradation, and inhibits PTK2 with an IC50 of 18 nM[1].

[1]. Popow J, et al. Highly Selective PTK2 Proteolysis Targeting Chimeras to Probe Focal Adhesion Kinase Scaffolding Functions. J Med Chem. 2019 Mar 14;62(5):2508-2520.

Avis

Review for Tos-PEG4-t-butyl ester

Average Rating: 5 ★★★★★ (Based on Reviews and 15 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Tos-PEG4-t-butyl ester

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.